Charlotte D C C van der Heijden

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 2

Top Topics

Venous Thromboembolism

Patient Reported

Coronavirus Disease

Top Venues

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Charlotte D C C van der Heijden, Rob Ter Heine, Emma J Kooistra, Roger J M Brüggemann, Jesper W J Walburgh Schmidt, Elke P L M de Grouw, Tim Frenzel, Peter Pickkers, Jenneke Leentjens
Effects of dalteparin on anti-Xa activities cannot be predicted in critically ill COVID-19 patients. British journal of clinical pharmacology 88 (6) (2022)
Charlotte D C C van der Heijden, Marleen L Duizer, Hanneke W H A Fleuren, Bart A Veldman, Tom Sprong, Anthonius S M Dofferhoff, Cornelis Kramers
Intravenous flucloxacillin treatment is associated with a high incidence of hypokalaemia. British journal of clinical pharmacology 85 (12) (2019)